• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[MY-5116和MY-1250的心血管效应]

[Cardiovascular effects of MY-5116 and MY-1250].

作者信息

Horii D, Hara Y, Hanazuka M, Nishi H

出版信息

Nihon Yakurigaku Zasshi. 1986 Apr;87(4):417-26. doi: 10.1254/fpj.87.417.

DOI:10.1254/fpj.87.417
PMID:3087848
Abstract

The effects of MY-5116, isoamyl 5,6-dihydro-7,8-dimethyl-4,5-dioxo-4H-pyrano [3,2-c]quinoline-2-carboxylate, an anti-allergic drug, and MY-1250, an active metabolite of MY-5116, on the cardiovascular system were studied in dogs, rats and guinea pigs. Orally administered MY-5116 (300 mg/kg) had no effect on the cardiovascular system in anesthetized dogs and conscious rats. In anesthetized dogs, MY-1250 and disodium cromoglycate (DSCG) caused hypotension, bradycardia and reduction of respiration rate from the doses of 3 and 10 micrograms/kg, i.v., respectively. Both drugs showed a tachyphylaxic phenomena which was crossed with each other. MY-1250-induced cardiovascular effects were abolished by bilateral vagotomy. MY-1250 (3-30 micrograms/kg, i.v.) caused a decrease of carotid blood flow, a transient decrease followed by a slight increase of renal blood flow, and a transient increase followed by a slight decrease of femoral blood flow in anesthetized dogs. MY-1250 had no effect on sympathetic ganglion, but increased the contractile force of isolated left atria from guinea pigs at 10(-5) g/ml and increased its rate at 10(-4) g/ml. These positive inotropic and chronotropic effects were not influenced by reserpinization. MY-1250 had no effect on the norepinephrine-induced dose-response curve in isolated rat aorta.

摘要

对一种抗过敏药物MY - 5116(5,6 - 二氢 - 7,8 - 二甲基 - 4,5 - 二氧代 - 4H - 吡喃并[3,2 - c]喹啉 - 2 - 羧酸异戊酯)及其活性代谢产物MY - 1250对犬、大鼠和豚鼠心血管系统的影响进行了研究。口服给予MY - 5116(300mg/kg)对麻醉犬和清醒大鼠的心血管系统无影响。在麻醉犬中,MY - 1250和色甘酸钠二钠(DSCG)分别静脉注射剂量为3和10μg/kg时会引起低血压、心动过缓和呼吸频率降低。两种药物均表现出快速耐受性现象,且相互交叉。双侧迷走神经切断可消除MY - 1250引起的心血管效应。在麻醉犬中,MY - 1250(静脉注射3 - 30μg/kg)会导致颈动脉血流量减少,肾血流量短暂减少后略有增加,股动脉血流量短暂增加后略有减少。MY - 1250对交感神经节无影响,但在10^(-5)g/ml时可增加豚鼠离体左心房的收缩力,在10^(-4)g/ml时可增加其心率。这些正性肌力和变时性作用不受利血平化的影响。MY - 1250对离体大鼠主动脉中去甲肾上腺素诱导的剂量 - 反应曲线无影响。

相似文献

1
[Cardiovascular effects of MY-5116 and MY-1250].[MY-5116和MY-1250的心血管效应]
Nihon Yakurigaku Zasshi. 1986 Apr;87(4):417-26. doi: 10.1254/fpj.87.417.
2
[General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].[曲克芦丁钠的一般药理作用。II. 对心血管系统的影响]
Nihon Yakurigaku Zasshi. 1983 Jul;82(1):79-92.
3
[Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents].[对大鼠腹腔渗出细胞介质释放的抑制作用以及对MY-5116和其他抗过敏药物介质的拮抗作用]
Nihon Yakurigaku Zasshi. 1986 Sep;88(3):229-37. doi: 10.1254/fpj.88.229.
4
Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.α2肾上腺素能受体拮抗剂咪达格列唑的药理学研究。第一部分:呼吸系统和心血管系统。
Arzneimittelforschung. 1991 Jan;41(1):9-18.
5
[Pharmacological effects of CM6912 and its main metabolites].
Nihon Yakurigaku Zasshi. 1985 Jul;86(1):71-85. doi: 10.1254/fpj.86.71.
6
[Effects of MY-5116 on PCA reaction and on the histamine release from peritoneal cells induced by antigen antibody reactions].[MY-5116对抗原抗体反应诱导的PCA反应及腹膜细胞组胺释放的影响]
Nihon Yakurigaku Zasshi. 1986 Jan;87(1):29-39. doi: 10.1254/fpj.87.29.
7
Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.新型选择性β2激动剂马布特罗的药理学研究。II:对心血管系统和平滑肌器官的影响。
Arzneimittelforschung. 1984;34(11A):1641-51.
8
Effects of brotizolam on cardiovascular functions and autonomic nervous system.
Arzneimittelforschung. 1986 Mar;36(3A):552-9.
9
In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)在多种动物体内和体外的研究。
Arzneimittelforschung. 1984;34(3A):342-6.
10
General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.新型抗血栓药物西洛他唑的一般药理学特性。第二部分:对周围器官的作用。
Arzneimittelforschung. 1985;35(7A):1163-72.